Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada
Introduction: Genetic testing in advanced prostate cancer is rapidly moving to become standard of care. Testing for genetic alterations in genes involved in DNA repair pathways, particularly those implicated in the homologous recombination repair (HRR) pathway, in patients with metastatic prostate c...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Urological Association
2022
|
Online Access: | View Fulltext in Publisher |